TABLE 1.
Clinicopathological characteristics of 128 glioblastoma patients
| Characteristic | Patients (N = 128)a | CDKL3 expression | |
|---|---|---|---|
| Low | High | ||
| Age (y) | |||
| <60 | 97 (75.8) | 50 | 47 |
| ≥60 | 31 (24.2) | 10 | 21 |
| Gender | |||
| Male | 87 (68.0) | 42 | 45 |
| Female | 41 (32.0) | 18 | 23 |
| Resection degree | |||
| Total | 90 (70.3) | 40 | 50 |
| Partial | 38 (29.7) | 20 | 18 |
| Chemotherapy | |||
| Yes | 93 (72.7) | 43 | 50 |
| No | 35 (27.3) | 17 | 18 |
| Radiotherapy | |||
| Yes | 93 (72.7) | 45 | 48 |
| No | 33 (25.8) | 13 | 20 |
| Unknown | 2 (1.5) | 1 | 1 |
| IDH1 | |||
| Mutant | 3 (2.4) | 1 | 2 |
| Wild‐type | 124 (97.6) | 59 | 65 |
| Survival status | |||
| Live | 12 (9.4) | 9 | 3 |
| Dead | 110 (85.9) | 46 | 64 |
| Unknown | 6 (4.7) | 5 | 1 |
Abbreviation: CDKL3, cyclin‐dependent kinase‐like 3.
a
Data are shown as n (%).